Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Singanayagam, A. Singanayagan, A. Hill, J.D. Chalmers (London, United Kingdom). Obesity is associated with improved outcome in community-acquired pneumonia. Eur Respir J 2012; 40: Suppl. 56, 1363

Member's Comments

No comment yet.

Related content which might interest you: Obesity is associated with improved survival in community-acquired pneumonia Source: Eur Respir J 2013; 42: 180-187 Year: 2013 Impact of obesity on outcomes for patients hospitalised with pneumonia Source: Eur Respir J 2013; 41: 929-934 Year: 2013 Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia Source: Eur Respir J 2009; 34: 932-939 Year: 2009 Thrombocytosis is a marker of poor outcome in community-acquired pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Obesity and outcomes in patients hospitalized for pneumonia Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections Year: 2012 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Azithromycin is associated with improved survival in patients with healthcare-associated pneumonia Source: International Congress 2017 – Update on community acquired pneumonia Year: 2017 The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Factors associated with unknown aetiology in patients with community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 560s Year: 2002 Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression Source: Eur Respir J 2012; 40: 1201-1210 Year: 2012 Factors affecting short and long-term mortality after community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Affecting factors of mortality in severe community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Factors associated with community-acquired pneumonia in-hospital mortality in Portugal Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 Prediction of complications development and lethal outcome in patients with community-acquired pneumonia Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Prediction of prognosis in healthcare-associated pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007 Physical deterioration during hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015 Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia Source: Eur Respir J 2007; 30: 517-524 Year: 2007